In CX3CL1 knockout mouse models in which Parkinson’s was induced, only the soluble form of fraktaline was shown to inhibit neurotoxicity, accompanied by improved motor impairment, prevention of dopaminergic neuronal loss, and reduced microglial activation in animals. Here, CX3CL1 is linked to Parkinson disease.